Inaccurate Glycosylated Hemoglobin A1C Measurements in Human Immunodeficiency Virus—Positive Patients with Diabetes Mellitus
Open Access
- 15 August 2003
- journal article
- case report
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 37 (4) , e53-e56
Abstract
Persistent differences in blood glucose and serum glycosylated hemoglobin (HbA1C) measurements were observed in 4 human immunodeficiency virus—positive patients with diabetes mellitus, all of whom were taking drugs associated with hemolysis, which interferes with the reliability of HbA1C levels. Determination of fructosamine levels was a more accurate alternative for measuring average glycemic control in these patients.Keywords
This publication has 10 references indexed in Scilit:
- Tests of Glycemia in DiabetesDiabetes Care, 2003
- Factors influencing ribavirin-induced hemolysisJournal of Hepatology, 2001
- Hemoglobin variants and determination of glycated hemoglobin (HbA1c)Diabetes/Metabolism Research and Reviews, 2001
- DAPSONE AND SULFAPYRIDINEDermatologic Clinics, 2001
- Disorders of Glucose Metabolism in Patients Infected with Human Immunodeficiency VirusClinical Infectious Diseases, 2000
- Increased Hepatic Iron Deposition Resulting From Treatment of Chronic Hepatitis C With RibavirinAmerican Journal of Clinical Pathology, 2000
- Decreased HbA1c Levels Due to Sulfonamide-Induced Hemolysis in Two IDDM PatientsDiabetes Care, 1996
- Interference of Dapsone in HbA1c Monitoring of a Type I Diabetic Patient With Necrobiosis LipoidicaDiabetes Care, 1994
- Increase in hepatic iron stores following prolonged therapy with ribavirin in patients with chronic hepatitis CJournal of Hepatology, 1994
- Drug-induced haemolysis and fast haemoglobin A1 in diabetes mellitus.BMJ, 1979